THE MEDICAL MANAGEMENT OF GLAU-COMA: HOW TO CHOOSE FIRST-LINE THERAPY

Several recent clinical studies (AGIS, CIGTS, OHTS, and EMGT) have shown the importance of lowering intraocular pressure (IOP) in slowing the progression of glaucomatous optic neuropathy. Other clinical trials have shown that reducing the diurnal fluctuation in IOP favors maintaining stable visual fields. Available prostaglandin analogues achieve IOP reductions